View Article

  • Awareness, Attitude, and Readiness Toward Artificial Intelligence and Digital Health Technologies Among Pharmacy Students as Future Healthcare Professionals: A Cross-Sectional Study

  • 1Department of Pharmacy, Dr. D. Y. Patil College of Pharmacy, Akurdi, Savitribai Phule Pune University, Pune – 411044, Maharashtra, India

Abstract

Background: With the changing landscape of healthcare delivery and the implementation of artificial intelligence (AI) and digital health technologies in medicine, including in the pharmacy, future pharmacists must have the competency in AI-based clinical decision support, electronic health records (EHRs), telepharmacy and medicare management software. Considering the paucity of available quantitative data regarding preparedness of the Indian pharmacy students, no composite validated Readiness Index (RI) has been developed thus far. Objectives: To evaluate the awareness, attitude and readiness of D.Pharm, B.Pharm, Pharm.D, and M.Pharm students towards AI and digital health technologies, to build a programme-specific Readiness Index, and to pinpoint readiness predictors. Methods: Methods: A cross-sectional study was conducted with 175 Pharmacy students from Pune, Maharashtra and a 49 item, 5 point Likert questionnaire was used. The composite RI was obtained by averaging the items related to readiness and was used to determine respondents' readiness level as High (>3.5), Moderate (2.5–3.5), or Low (<2.5). One-way ANOVA, chi-square test and Pearson's correlation (SPSS v23.0; p<0.05) were applied for data analysis. Results: Mean Awareness, Attitude, and Readiness scores were 3.97±0.78, 4.10±0.81, and 4.06±0.81, respectively. High, Moderate, and Low readiness levels were observed in 77.7% (n=136), 20.0% (n=35), and 2.3% (n=4) of participants. Attitude was the most significant predictor of readiness (r=0.755, p<0.001), with 72.0% agreeing to the incorporation of AI into the curriculum, and taking the workshops was associated with higher scores than not taking them (4.17 vs. 3.94). Conclusion: Indian pharmacy students were found to be highly aware of AI and digital health technologies, having positive attitudes and overall readiness for them It is suggested to incorporate structured curricular integration to build digital competency of the future health care professionals.

Keywords

Artificial intelligence; Digital health; Pharmacy education; Readiness Index; Cross-sectional study; Pharmacy students

Introduction

× Popup Image

Artificial Intelligence (AI), simply put, the ability of a computer-based system to learn, reason and recognize patterns—processes that have traditionally been the domain of human intelligence, is now being woven into the fabric of modern healthcare delivery systems. In the context of pharmacy practice, AI-driven solutions are helping to support healthcare practitioners by assisting with drug interaction alerts, automated dispensing systems, AI-driven adherence reminders, and clinical decision support systems. The pharmacist's job responsibilities have transcended the role of a mere dispenser to include electronic health records (EHRs), telemedicine, mobile health (mHealth) applications, telepharmacy services and real time data analysis. The transformation is being accelerated by national initiatives like Ayushman Bharat Digital Mission (ABDM) and the National Digital Health Mission (NDHM) to create a federated digital health infrastructure, which are pushing pharmacists towards working amidst more data-driven systems.3,4 Globally, digital health competence is also officially included in the Education Development Goals for Pharmacy Education (FIP) 2020 and the WHO Governance Framework for AI in Health (2021), which highlight the importance of a digitally competent workforce. 4,5

Review of Literature

To set the present study in the context of the global AI readiness for health care and pharmacy education, a literature review was conducted for the last seven years (2018–2025). The majority of international knowledge-attitude-practice (KAP) studies are from Sub Saharan Africa, the Middle East and Southeast Asia. In Zambia, Mudenda et al. (2024) found that 71.3% of pharmacy students had limited knowledge of AI and negative attitudes towards its use despite reporting frequent self-reported usage.6 In Saudi Arabia, Alhur et al. (2025) indicated that 79.8% of healthcare professionals had received no formal training in AI, with 72.9% stating they considered its impact on health outcomes positive.7  In the Indian context, Tezpal et al. (2024) reported that 79.8% of healthcare professionals had not had any formal training sessions on AI and 72.9% had a positive view on its impact on health outcomes.8

 The articles reviewed generally share positive sentiments and awareness of AI, but there are no quantitative measures of readiness validated within this population. This is the first study that (i) has developed a composite Readiness Index for all the pharmacy programmes in India, (ii) has compared the Readiness Index of the programmes across one another D.Pharm, B.Pharm, Pharm.D, and M.Pharm. On the other hand, the second cohort of pharmacy students analysed the association between formal educational AI exposure and preparedness (iii) or the third cohort analysed the association between formal education exposure and readiness in Indian pharmacy students. The present study fills these three gaps by analyzing the readiness of 175 students from four Pharmacy programmes and creating a programme specific composite Readiness Index validated.

Table 1: Summary Of Key Published Studies On Ai Awareness, Attitude, And Readiness Among Pharmacy/Healthcare Students

Sr.

Author(s), Year, Journal

Study Focus

Key Finding

Research Gap

1

Mudenda et al., 2024; Creative Education6

KAP survey – 262 pharmacy students, Zambia

71.3% inadequate knowledge; 71.3% negative attitude; 91.6% used AI in studies but only 1.1% attended an AI workshop

No readiness index; single institution; no programme-wise comparison

2

Tezpal et al., 2024; J Marine Med Soc8

AI perception & readiness – 402 healthcare professionals, India

79.8% never attended an AI course; 72.9% believed AI improves health outcomes; preparedness scores low

No pharmacy-specific analysis; no RI developed

3

Alhur et al., 2025; J Pioneering Med Sci7

Attitudes toward AI – 501 pharmacy students, Saudi Arabia

48.6% moderately familiar; 62.95% likely to adopt AI; significant gender and year-of-study differences (p<0.001)

No readiness index; no Indian data; no awareness section

4

Sit et al., 2020; J Med Internet Res13

AI attitudes – healthcare professionals, UK

Moderate awareness, positive attitudes; structured training urgently needed

No pharmacy students; no RI; qualitative methodology

5

Sharma et al., 2021; NPJ Digital Medicine15

Digital health technology review – clinical care

EHRs and AI tools increasingly embedded; readiness gap documented; curriculum integration needed

No primary data; no pharmacy-specific RI

6

Busch et al., 2024; Br J Clin Pharmacol10

Multinational – international pharmacy students, AI perceptions

Generally positive attitudes; limited practical exposure and knowledge of AI applications

No Indian cohort; no programme-wise RI

7

Hasan et al., 2024; PLOS ONE12

KAP – pharmacy students & faculty, MENA region

Positive attitudes prevalent; knowledge of AI applications limited; job-security concerns raised

No readiness index; different cultural context

8

O’Connor & Yan, 2022; Int J Med Informatics14

Systematic review – healthcare professionals’ AI perceptions

Positive attitudes but limited readiness and training; need for readiness assessment among students

No primary data; no pharmacy-specific findings

9

Mesko & Győrffy, 2022; J Med Internet Res16

AI in healthcare – education and workforce preparedness

AI education necessary for digital health workforce; current curricula inadequate

No primary survey; no RI for students

10

Davenport & Kalakota, 2019; Future Healthcare J2

AI potential in healthcare

AI as a transformative healthcare tool; pharmacists must acquire new digital competencies

Conceptual review only; no empirical student data

Objectives of the Study

The aims of the study are:

Primary Objective: To assess the awareness, attitude and preparedness of the students in the pharmacy profession regarding AI and DH technologies and to develop a composite Readiness Index (RI) as a quantitative measure of preparedness.

Secondary Objectives:

  1. To evaluate awareness and attitude profile of students within all programme levels.
  2. To find out the programme-specific (D.Pharm, B.Pharm, Pharm.D, M.Pharm) distribution of readiness.
  3. To determine High, Moderate or Low Readiness Index of the participants.
  4. Educational exposure (theoretical, practical and workshop) and readiness scores will be explored.
  5. To use inferential statistical tests to distinguish between differences across genders and programmes in the domains.
  6. Identify relationship between predictor variables and readiness by conducting the Pearson correlation analysis.

MATERIALS AND METHODS

Study Design and Setting

The study was observational (cross sectional) with a questionnaire. The data were gathered from the students of the Pharmacy profession from January to March 2026 from various pharmacy institutions in Pune, Maharashtra, India, which are private, autonomous, and government institutions.

Sample Size and Study Population

The students who participated were those in the D.Pharm, B.Pharm, Pharm.D, and M.Pharm programmes. A minimum sample size of 100 was determined using Yamane's formula with a prevalence (awareness) assumed to be 50% (conservative estimate), a 95% confidence interval and a precision of 5%. 175 valid responses were received, which was more than the minimum required, thus providing sufficient power in the statistical analysis.

Inclusion and Exclusion Criteria

Inclusion: Students currently enrolled in the D.Pharm, B.Pharm, Pharm.D, or M.Pharm programmes who provided informed electronic consent and completed the questionnaire in full.

Exclusion: Students from non-pharmacy disciplines, respondents who did not consent or provided incomplete responses, and duplicate entries identified during data cleaning.

Survey Tool and Data Collection

The questionnaire was built de novo, based on published literature and consisted of six sections: (A) Demographic Information (6 items); (B) Awareness (5 Likert items); (C) Attitude (5 Likert items); (D) General Readiness (5 Likert items); and (E1–E4) Programme-Specific Readiness (6 items each for D.Pharm, B.Pharm, Pharm.D, and M.Pharm, respectively). A five-point Likert scale (from Strongly Disagree to Strongly Agree) was used for all the items. The questionnaire was made up on Google Forms and given online. The internal consistency was checked by Cronbach's alpha, and resulted in a value of 0.84, which shows good internal consistency. Some typical items in each domain are shown in Table 2.

Table 2: Domain Questions In The Sample Survey

Sr.

Domain

Sample Question

Scale

1

Awareness

I am aware that artificial intelligence is used in healthcare systems

1(SD)–5(SA)

2

Awareness

I am familiar with electronic health records and digital patient data systems

1(SD)–5(SA)

3

Awareness

I am aware of telemedicine and telepharmacy services

1(SD)–5(SA)

4

Attitude

AI and digital health technologies can improve healthcare quality

1(SD)–5(SA)

5

Attitude

Pharmacists should adapt to emerging healthcare technologies

1(SD)–5(SA)

6

Attitude

Learning about AI and digital health is important for my career

1(SD)–5(SA)

7

Readiness

I feel prepared to use digital health tools in my future profession

1(SD)–5(SA)

8

Readiness

I am confident in adapting to new healthcare technologies

1(SD)–5(SA)

9

Readiness

I am willing to undergo training related to AI and digital health

1(SD)–5(SA)

10

Programme-Specific (B.Pharm)

AI can support drug discovery and pharmaceutical research

1(SD)–5(SA)

11

Programme-Specific (Pharm.D)

AI-based systems help detect drug–drug interactions

1(SD)–5(SA)

12

Programme-Specific (M.Pharm)

AI, including machine learning, supports formulation development

1(SD)–5(SA)

13

Educational Exposure

I have received theoretical exposure to AI or digital health

1(SD)–5(SA)

14

Educational Exposure

AI should be incorporated into the pharmacy syllabus

1(SD)–5(SA)

15

Educational Exposure

I have received practical exposure to digital health tools

1(SD)–5(SA)

SD = Strongly Disagree; SA = Strongly Agree.

Readiness Index (RI)

 A composite Readiness Index was determined by taking the average of all the readiness items (D and E) for each respondent for a 1-5 scale. The participants were divided into three readiness groups: High (RI > 3.5), Moderate (RI 2.5 – 3.5) and Low (RI < 2.5). It is a composite measure that allows a single "standardised" measure of preparedness that can be used across programmes and over time. 17

Statistical Analysis

IBM SPSS version 23.0 was used to analyse the data. The scores were derived by averaging the underlying items to the result in domain scores. All variables were subject to descriptive statistics (mean, standard deviation, frequency and percentage). In order to compare the results across the programmes, one-way ANOVA were conducted, gender comparisons were conducted by independent-samples t-test, associations between categorical variables and readiness were conducted using chi-squares and associations between domains were conducted using Pearson’s correlation test. A p value of <0.05 (two-tailed) was considered statistically significant.

Ethical Considerations

Electronic informed consent was obtained from all participants before participation. The study complied with the Declaration of Helsinki. Institutional ethics approval was not required for this anonymous questionnaire-based educational survey as per institutional policy.

RESULTS

Sociodemographic Characteristics

A total of 175 pharmacy students met the inclusion criteria. Table 3 summarises their sociodemographic profile.

Table 3: Sociodemographic Characteristics Of Participants (N=175)

Variable

Category

n

%

Cumulative %

Gender

Female

103

58.9

58.9

 

Male

71

40.6

99.5

 

Prefer not to say

1

0.6

100.0

Programme

B.Pharm

85

48.6

48.6

 

D.Pharm

30

17.1

65.7

 

M.Pharm

30

17.1

82.8

 

Pharm.D

30

17.1

100.0

Year of Study

1st Year

55

31.4

31.4

 

2nd Year

41

23.4

54.8

 

3rd Year

20

11.4

66.2

 

4th Year

54

30.9

97.1

 

5th Year

5

2.9

100.0

Institution Type

Private

95

54.3

54.3

 

Autonomous

72

41.1

95.4

 

Government

8

4.6

100.0

AI Workshop Attendance

Yes

90

51.4

51.4

 

No

85

48.6

100.0

Women had a higher participation rate than men (58.9% vs. 40.6%), which also reflects the global trend of higher female enrolment in pharmacy education. B.Students in the Pharm group were the largest subgroup (48.6%) and the private institutions had the highest percentage of respondents (54.3%). Significantly, 51.4% of respondents said they had already had experience with AI or digital health training prior to the class, showing a high level of engagement with technology-based education outside of the classroom.

 

 

Figure 1: Gender, Programme, and Institution-type Distribution of Participants (N=175)

 

 

Figure 2: AI/Digital Health Workshop Attendance Among Participants (N=175)

Overall Domain Scores

Table 4 presents the mean scores across the three domains.

Table 4: Overall Mean Domain Scores (N=175)

Domain

Mean Score

Std. Deviation

Min

Max

Awareness Score

3.97

0.78

1.0

5.0

Attitude Score

4.10

0.81

1.0

5.0

Readiness Score

4.06

0.81

1.0

5.0

Readiness Index (Composite)

4.08

0.75

1.0

5.0

The general orientation towards AI and digital health was moderate to high, with all three domain scores being higher than 3.97 out of 5.0 points. Students' scores for the Attitude domain (4.10) were the highest of all the three domains, indicating that they were aware of the significance of AI and had a positive attitude towards its application in practice. The overall composite Readiness Index for the cohort was 4.08±0.75, which is classified as High Readiness

 

Figure 3: Overall Mean Domain Scores with Standard Deviation Error Bars (N=175). The dashed line marks the High Readiness threshold (3.5).

Item-wise Awareness Scores

Table 5: Item-Wise Awareness Scores (N=175)

Sr.

Awareness Item

Mean

SD

1

I am aware of the basic concept of digital health in healthcare

3.87

0.91

2

I am aware that artificial intelligence is used in healthcare systems

4.11

0.89

3

I am aware that digital tools are used in pharmacy practice

4.12

0.86

4

I am familiar with electronic health records and digital patient data systems

3.93

0.94

5

I am aware of telemedicine and telepharmacy services

3.80

1.01

 

Overall Awareness Score

3.97

0.78

Items that scored the highest (4.12) relevant to awareness of digital tools in pharmacy practice, and (4.11) applications of AI in healthcare systems, demonstrated good conceptual awareness of the use of digital tools in professional practice. The lowest rated item was related to knowledge about telemedicine and telepharmacy services (3.80), suggesting a curricular deficiency in exposure to patient-facing service delivery via technology.

 

Figure 4: Item-wise Awareness Mean Scores (N=175). Dashed line marks the 3.5 threshold.

Item-wise Attitude Scores

Table 6: Item-Wise Attitude Scores (N=175)

Sr.

Attitude Item

Mean

SD

1

AI and digital health technologies can improve healthcare quality

4.02

0.92

2

Integration of AI into pharmacy practice is necessary for the future

4.02

0.96

3

Digital technologies can improve efficiency in pharmaceutical care

4.13

0.87

4

Pharmacists should adapt to emerging healthcare technologies

4.18

0.90

5

Learning about AI and digital health is important for my career

4.14

0.91

 

Overall Attitude Score

4.10

0.81

All five attitude items scored above 4.0, reflecting strong overall agreement. The highest-rated item, “Pharmacists should adapt to emerging healthcare technologies” (4.18), underscores students’ sense of professional responsibility toward technological change, while the item on the career relevance of AI learning (4.14) further supports the case for curricular integration.

 

Figure 5: Item-wise Attitude Mean Scores (N=175). All items exceed the High threshold (3.5).

Readiness Level Distribution and Readiness Index

Table 7: Readiness Index Classification By Programme (N=175)

Programme

n

High Readiness n (%)

Moderate Readiness n (%)

Low Readiness n (%)

Mean RI ± SD

B.Pharm

85

61 (71.8%)

22 (25.9%)

2 (2.4%)

3.94±0.82

D.Pharm

30

25 (83.3%)

5 (16.7%)

0 (0.0%)

4.13±0.74

M.Pharm

30

23 (76.7%)

6 (20.0%)

1 (3.3%)

4.14±0.76

Pharm.D

30

27 (90.0%)

2 (6.7%)

1 (3.3%)

4.24±0.70

Total

175

136 (77.7%)

35 (20.0%)

4 (2.3%)

4.08±0.75

F=1.298, p=0.277 (ANOVA – not significant).

The overall preparedness was strong, with most students (77.7%) being considered as having High Readiness to use AI and digital health technologies in professional practice. Pharm.D students had the greatest percentage of High Readiness (90.0%), followed by B.Pharm. The highest percentage (25.9%) was observed among the Pharm students indicating that undergraduate students were a priority group for targeted curricular interventions. The non-significant result for the ANOVA (p=0.277) is not necessarily a sign of no meaningful differences in readiness between cohorts at the programme level but rather that there are no meaningful programme-level differences across cohorts.

 

 

Figure 6: Overall and Programme-wise Readiness Level Distribution (N=175)

Programme-wise Domain Score Comparison

Table 8: Programme-Wise Comparison Of Domain Scores (Mean ± Sd)

Programme

Awareness

Attitude

Readiness

ANOVA p-value

B.Pharm (n=85)

3.81±0.80

4.07±0.83

3.94±0.82

 

D.Pharm (n=30)

4.05±0.72

3.97±0.79

4.13±0.74

 

M.Pharm (n=30)

3.97±0.76

4.08±0.80

4.14±0.76

 

Pharm.D (n=30)

4.35±0.70

4.32±0.75

4.24±0.70

 

Overall (n=175)

3.97±0.78

4.10±0.81

4.06±0.81

p=0.277 (NS)

The mean scores for each of the three domains — Awareness, Attitude, and Readiness — were highest for Pharm.D students, which supports their clinically oriented curriculum where EHRs, AI-powered drug-interaction software, and clinical decision-support systems are used regularly. Students in the B.Pharmacy Department had the lowest score in Awareness (3.81) and Readiness (3.94) most likely because they are mostly pre-clinical students of the Pharmacy undergraduate programme.

 

Figure 7: Programme-wise Comparison of Awareness, Attitude, and Readiness Scores (N=175)

Gender-wise Analysis

Table 9: Gender-Wise Domain Score Comparison (N=174*)

Domain

Female (n=103) Mean ± SD

Male (n=71) Mean ± SD

p-value (t-test)

Awareness Score

3.88±0.79

4.10±0.75

0.072 (NS)

Attitude Score

4.08±0.82

4.13±0.80

0.681 (NS)

Readiness Score

4.06±0.82

4.05±0.80

0.954 (NS)

χ² (Gender vs. Readiness Level)

χ²=3.413

df=4

p=0.491 (NS)

*One respondent who selected “Prefer not to say” excluded. NS = Not Significant.

There were no significant differences between the sexes in any domain (all p>0.05), suggesting that awareness, attitude and readiness towards digital health is fairly gender balanced throughout Indian pharmacy education. This is in contrast to reports from Zambia and Saudi Arabia where profound gender effects were reported.6,7

Correlation Analysis

Table 10: Pearson’s Correlation Matrix – Awareness, Attitude, And Readiness Scores

 

Awareness Score

Attitude Score

Readiness Score

Awareness Score

1.000

0.598**

0.543**

Attitude Score

0.598**

1.000

0.755**

Readiness Score

0.543**

0.755**

1.000

**p<0.001 (two-tailed).

There was a strong positive correlation between Attitude and Readiness (r=0.755, p<0.001), indicating that a positive professional attitude is a key factor to be considered in assessing digital health readiness. The moderate correlation between Awareness and Attitude (r=0.598) and the Awareness with Readiness (r=0.543) further supports the interdependency of these constructs as it is suggested by the TAM that the attitude construct namely perceived usefulness is the major determinant of behavioural intention to adopt new technology. 11

 

Figure 8: Pearson’s Correlation Heatmap Among Domain Scores. Darker shading indicates stronger correlation.

Educational Exposure Analysis

Table 11: Educational Exposure Distribution And Association With Readiness Scores (N=175)

Item

Agree/SA n (%)

Neutral n (%)

Disagree/SD n (%)

Mean Readiness Score

Theoretical exposure to AI/digital health

117 (66.9%)

43 (24.6%)

15 (8.6%)

4.19

AI should be incorporated in syllabus

126 (72.0%)

42 (24.0%)

7 (4.0%)

4.22

Practical exposure to digital health tools

119 (68.0%)

41 (23.4%)

15 (8.6%)

4.21

Workshop/Training Attendance – Yes

90 (51.4%)

4.17

Workshop/Training Attendance – No

85 (48.6%)

3.94

 SA = Strongly Agree; SD = Strongly Disagree. Mean Readiness Scores shown for students in respective exposure subgroups.

 

Figure 9: Educational Exposure Response Distribution by Item (N=175). SD=Strongly Disagree, D=Disagree, N=Neutral, A=Agree, SA=Strongly Agree.

DISCUSSION

The study is one of the first studies to measure AI and digital health readiness across four levels of the pharmacy programmes within a single national cohort of 175 Indian pharmacy students. In general, students exhibited moderate to high levels of awareness, positive attitudes and mainly high readiness (77.7%) to the AI and digital health technologies.

The overall Awareness score (3.97±0.78) indicates medium awareness of AI applications in healthcare. The Attitude score (4.10) was the highest of the three domains, suggesting a strong positive attitude towards AI adoption. This is an opposite result to that of Mudenda et al. (2024) that pharmacy students in Zambia (71.3%) have negative attitudes towards technology; this difference could be attributed to the differences in educational infrastructure, access to digital technology, and the socio-technological environment across Sub-Saharan Africa and India. The present results are more consistent with the results of Alhur et al. (2025) in Saudi Arabia, who found mostly positive attitudes towards AI and Busch et al. (2024) in their multinational sample who found mostly positive attitudes towards AI. 7,10

Cross-section analysis of the relationship between attitude and readiness yielded a positive correlation (r=0.755, p<0.001) and it is recommended that attitude-centred educational programs (e.g. case studies, exposure to practising professionals, and AI success stories in the field of Pharmacy) be incorporated alongside knowledge-based education to improve practical readiness. Motivation and fact therefore must be included in the curriculum design.

The observed programme-wise gradient (Pharm.D > M.Pharm > D.Pharm > B.Pharm) is consistent with the clinical orientation of the Pharm.D curriculum, which affords frequent exposure to patient-care systems, drug databases, and EHRs. This pattern parallels the findings of Alhur et al. (2025), who identified year of study as a key determinant of AI familiarity and adoption intention among pharmacy students. The higher proportion of Moderate Readiness among B.Pharm students (25.9%) relative to Pharm.D students (6.7%) strengthens the argument for introducing AI and digital health content earlier in the undergraduate curriculum, prior to the clinical training phase.

Contrary to the results of Mudenda et al. (2024) and Alhur et al. (2025), women and men did not significantly differ in their AI-related knowledge, attitude and practice in the present study, which can be attributed to relatively homogeneous digital environment of Indian pharmacy students where knowledge, attitude and practices related to using smartphones, social media and information seeking is mostly independent of gender.6,7  This result could also be due to selection bias, because those who agree to take part in an AI-literacy survey might already constitute a sub-sample with higher levels of technology engagement. The higher preparedness scores of the workshop participants when compared with those who did not attend the workshop (4.17 vs. 3.94) confirms the findings of Tezpal et al.2014 who reported a similar association between the exposure to structured AI-course and preparedness (r=0.426, p<0.001)8 thereby reinforcing the importance of implementing AI and digital health workshops, seminars, or short courses as a complementary part of the pharmacy curriculum, which was strongly supported by 72.0% of the surveyed students, compared to the formal incorporation of these courses.

 In addition to the empirical results, this study contributes to the methodology as the composite Readiness Index can be used as a standardised, reusable tool to measure programme and institutional-level readiness and to monitor progress after educational interventions.

CONCLUSION

The study, which was cross-sectional, included 175 students from four levels of pharmacy programmes across India and evaluated their awareness, attitude and preparedness to AI and digital health technologies using a newly created composite Readiness Index. The key findings are: (i) awareness was moderate to high, with the highest scores in healthcare and pharmacy practice with digital tools (mean, 3.97±0.78); (ii) a strong endorsement of attitudes at all programme levels (mean, 4.10±0.81); and (iii) a strong positive association between workshop attendance and readiness (4.17 vs. 3.94). The overall findings show a positive outlook of the Indian pharmacy students towards incorporating AI and digital health into their education. There are still areas lacking in knowledge, however, such as telepharmacy, EHRs and more sophisticated applications of AI, most prominently among B.Pharm students, with focus on priority areas of curricular intervention. The created Readiness Index in this study is a legitimate and reusable indicator to be used in long term evaluation and institutional comparison of educational programs on AI in Pharmacy programs.

Recommendations
1. The Pharmacy Council of India (PCI) should promote curricular integration of a dedicated course on AI and digital health technologies across the B.Pharm, D.Pharm, Pharm.D, and M.Pharm curricula, incorporating programme-specific content such as dispensing automation for D.Pharm, AI applications in drug discovery for B.Pharm, clinical decision support for Pharm.D, and pharmacovigilance analytics for M.Pharm.

2. Institutions should introduce a foundational AI and Digital Health Literacy course for first-year students across all programmes, covering AI fundamentals, EHRs, telemedicine, telepharmacy, and AI ethics.

3. Faculty should be encouraged to collaborate across disciplines — pharmacy, computer science, and health informatics — to develop blended-learning modules incorporating AI simulations and case-based digital health instruction.

4. Institutions should invest in dedicated digital-health laboratories equipped with EHR simulation platforms, AI-based drug-interaction tools, and telepharmacy practice modules.

5. Faculty development programmes should be implemented to strengthen educator competency in AI applications relevant to pharmacy practice.

6. AI-related workshops, webinars, hackathons, and industry–academia collaborative projects should be incorporated into the academic calendar as a complement to formal coursework

Limitations

Because of the cross-sectional design, it is not possible to draw causal conclusions about the relationship between readiness and educational exposure; factors other than those examined may be acting as confounding factors. The results may not be generalisable to other parts of India because the sampling was done from a convenience sample and the study was conducted in a geographically limited area of Pune, Maharashtra. The data is self-reported, which can lead to social-desirability bias, causing people to report their attitudes and willingness to adopt AI to be higher than they truly are. Construct validation of the Readiness Index with objective measures of clinical or research use of AI-tools is warranted, as the Readiness Index showed good internal consistency (α=0.84). Finally, the relatively small subgroup sizes for D.Pharm, M.Pharm, and Pharm.D (n=30 each) constrain the statistical power of inter-programme comparisons.

Future Scope:

Causal evidence for the effectiveness of educational interventions on changes in Awareness, Attitude, and Readiness Index scores would come from structured curricular interventions focused on AI and followed up with longitudinal studies. The study would be more generalizable to the larger, more diverse sample of Indian students in their pharmacy studies if performed in multi-institutional and multi-state studies. Qualitative research would be useful to understand the reasons for reduced preparedness within sub groups and could be complementary. Faculty readiness assessment and aptitude assessment of the students in AI and digital health can be conducted in parallel to find further gaps in the educational system. Additional construct validation with objective behavioral measures (e.g. frequency and confidence of using the EHR or interaction with clinical decision support systems) would increase the construct validity of the Readiness Index. A comparative analysis of the knowledge and practice gap in this could be further illumination between the knowledge and practice gap by comparing pharmacy students with practising pharmacists.

FUNDING

No external funding was received. This study was conducted as part of the Final Year B.Pharm Project at Dr. D. Y. Patil College of Pharmacy, Akurdi, Pune.

AI DECLARATION

Generative artificial intelligence tools, including ChatGPT (OpenAI), were used during manuscript preparation for language refinement, grammar correction, formatting assistance, and organisation of content. All aspects of study design, data collection, statistical analysis, interpretation of results, and scientific conclusions were performed and verified by the authors, who take full responsibility for the accuracy, originality, and integrity of the manuscript.

CONFLICT OF INTEREST

The authors declare no conflicts of interest.

ACKNOWLEDGEMENT

The authors gratefully acknowledge the participation of all pharmacy students who took part in this study.

REFERENCES

  1. Topol EJ: High-performance medicine: the convergence of human and artificial intelligence. Nature Medicine 2019; 25(1):44-56.
  2. Davenport T and Kalakota R: The potential for artificial intelligence in healthcare. Future Healthcare Journal 2019; 6(2):94-98.
  3. Ministry of Health and Family Welfare, Government of India: Ayushman Bharat Digital Mission. New Delhi: MoHFW, 2021.
  4. World Health Organization: Ethics and Governance of Artificial Intelligence for Health. Geneva: WHO, 2021.
  5. International Pharmaceutical Federation (FIP): Digital Health in Pharmacy Education and Practice. The Hague: FIP, 2020.
  6. Mudenda S, Lubinda R, Kasanga M, Musakuzi Z, Mohamed S and Mufwambi W: Artificial Intelligence: a knowledge, attitude, and practices survey among pharmacy students at the University of Zambia. Creative Education 2024; 15:2582-2596.
  7. Alhur AA, Alsaeed W, Albalawi B et al: Pharmacy students’ attitudes towards AI in pharmaceutical practices. Journal of Pioneering Medical Sciences 2025; 14(7):132-137.
  8. Tezpal M, Ghosh S, Lalwani R, Yadav J and Yadav AK: Artificial intelligence in health care: a study on perceptions of and readiness for artificial intelligence in health-care professionals. Journal of Marine Medical Society 2024; 26(3):376-381.
  9. Swed S, Alibrahim H, Elkalagi NKH et al: Knowledge, attitude, and practice of artificial intelligence among doctors and medical students in Syria: a cross-sectional online survey. Frontiers in Artificial Intelligence 2022; 5:1011524.
  10. Busch F, Hoffmann L, Truhn D et al: International pharmacy students’ perceptions towards artificial intelligence in medicine: a multinational, multicentre cross-sectional study. British Journal of Clinical Pharmacology 2024; 90:649-661.
  11. Davis FD: Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Quarterly 1989; 13(3):319-340.
  12. Hasan HE, Jaber D, Al Tabbah S et al: Knowledge, attitude and practice among pharmacy students and faculty members towards artificial intelligence in pharmacy practice: a multinational cross-sectional study. PLOS ONE 2024; 19:e0296884.
  13. Sit C, Srinivasan R, Amlani A et al: Attitudes and perceptions of UK medical students towards artificial intelligence and radiology: a multicentre survey. Journal of Medical Internet Research 2020; 22(4):e16614.
  14. O’Connor S and Yan Y: Healthcare professionals’ perceptions of artificial intelligence: a systematic review. International Journal of Medical Informatics 2022; 163:104738.
  15. Sharma A, Harrington RA, McClellan MB et al: Using digital health technology to improve clinical care. NPJ Digital Medicine 2021; 4:59.
  16. Mesko B and Győrffy Z: The rise of artificial intelligence in healthcare: implications for education and workforce preparedness. Journal of Medical Internet Research 2022; 24(6):e37015.
  17. Parasuraman A: Technology Readiness Index (TRI): a multiple-item scale to measure readiness to embrace new technologies. Journal of Service Research 2000; 2(4):307-320.
  18. Alshahrani MM, Alqahtani F, Alqahtani N et al: Artificial intelligence readiness among health sciences students: a cross-sectional study. BMC Medical Education 2025; 25:112.
  19. McCoy AB, Wright A and Sittig DF: Clinical decision support and digital health technologies in pharmacy practice. American Journal of Health-System Pharmacy 2021; 78(8):675-684.
  20. Murray E, Hennessey J, Davis K et al: Digital health education in pharmacy curricula: a scoping review. Journal of the American Medical Informatics Association 2024; 31(3):732-741.

Reference

  1. Topol EJ: High-performance medicine: the convergence of human and artificial intelligence. Nature Medicine 2019; 25(1):44-56.
  2. Davenport T and Kalakota R: The potential for artificial intelligence in healthcare. Future Healthcare Journal 2019; 6(2):94-98.
  3. Ministry of Health and Family Welfare, Government of India: Ayushman Bharat Digital Mission. New Delhi: MoHFW, 2021.
  4. World Health Organization: Ethics and Governance of Artificial Intelligence for Health. Geneva: WHO, 2021.
  5. International Pharmaceutical Federation (FIP): Digital Health in Pharmacy Education and Practice. The Hague: FIP, 2020.
  6. Mudenda S, Lubinda R, Kasanga M, Musakuzi Z, Mohamed S and Mufwambi W: Artificial Intelligence: a knowledge, attitude, and practices survey among pharmacy students at the University of Zambia. Creative Education 2024; 15:2582-2596.
  7. Alhur AA, Alsaeed W, Albalawi B et al: Pharmacy students’ attitudes towards AI in pharmaceutical practices. Journal of Pioneering Medical Sciences 2025; 14(7):132-137.
  8. Tezpal M, Ghosh S, Lalwani R, Yadav J and Yadav AK: Artificial intelligence in health care: a study on perceptions of and readiness for artificial intelligence in health-care professionals. Journal of Marine Medical Society 2024; 26(3):376-381.
  9. Swed S, Alibrahim H, Elkalagi NKH et al: Knowledge, attitude, and practice of artificial intelligence among doctors and medical students in Syria: a cross-sectional online survey. Frontiers in Artificial Intelligence 2022; 5:1011524.
  10. Busch F, Hoffmann L, Truhn D et al: International pharmacy students’ perceptions towards artificial intelligence in medicine: a multinational, multicentre cross-sectional study. British Journal of Clinical Pharmacology 2024; 90:649-661.
  11. Davis FD: Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Quarterly 1989; 13(3):319-340.
  12. Hasan HE, Jaber D, Al Tabbah S et al: Knowledge, attitude and practice among pharmacy students and faculty members towards artificial intelligence in pharmacy practice: a multinational cross-sectional study. PLOS ONE 2024; 19:e0296884.
  13. Sit C, Srinivasan R, Amlani A et al: Attitudes and perceptions of UK medical students towards artificial intelligence and radiology: a multicentre survey. Journal of Medical Internet Research 2020; 22(4):e16614.
  14. O’Connor S and Yan Y: Healthcare professionals’ perceptions of artificial intelligence: a systematic review. International Journal of Medical Informatics 2022; 163:104738.
  15. Sharma A, Harrington RA, McClellan MB et al: Using digital health technology to improve clinical care. NPJ Digital Medicine 2021; 4:59.
  16. Mesko B and Gy?rffy Z: The rise of artificial intelligence in healthcare: implications for education and workforce preparedness. Journal of Medical Internet Research 2022; 24(6):e37015.
  17. Parasuraman A: Technology Readiness Index (TRI): a multiple-item scale to measure readiness to embrace new technologies. Journal of Service Research 2000; 2(4):307-320.
  18. Alshahrani MM, Alqahtani F, Alqahtani N et al: Artificial intelligence readiness among health sciences students: a cross-sectional study. BMC Medical Education 2025; 25:112.
  19. McCoy AB, Wright A and Sittig DF: Clinical decision support and digital health technologies in pharmacy practice. American Journal of Health-System Pharmacy 2021; 78(8):675-684.
  20. Murray E, Hennessey J, Davis K et al: Digital health education in pharmacy curricula: a scoping review. Journal of the American Medical Informatics Association 2024; 31(3):732-741.

Photo
Sakshi Mandekar
Corresponding author

Department of Pharmacy, Dr. D. Y. Patil College of Pharmacy, Akurdi, Savitribai Phule Pune University, Pune – 411044, Maharashtra, India

Photo
Tejashree Deokule
Co-author

Assistant Professor, Department of Pharmaceutical Chemistry Dr. D. Y. Patil College of Pharmacy, Akurdi

Sakshi Mandekar 1*, T. Deokule, Awareness, Attitude, And Readiness Toward Artificial Intelligence And Digital Health Technologies Among Pharmacy Students As Future Healthcare Professionals: A Cross-Sectional Study , Int. J. of Pharm. Sci., 2026, Vol 4, Issue 7, 5866-5883.https://doi.org/10.5281/zenodo.21705879

More related articles
Comprehensive Review of Pazopanib with Low Oral Ef...
Durga Madhab Nayak, Dr. Debasish Ghose, Dr.Sambit Kumar Parida...
A Comprehensive Review on RP-HPLC Method Developme...
Vanita Sawant, Pratiksha Wagh, Nikita Mawal, Smita Aher...
Analytical Method Development and Validation for Q...
Arpit Shinganjude, Nandini Tale, Shrutika Kawane, Shyamkumar Dabh...
COPD: A Review...
Ranvijay Kumar Singh , Lalit Kumar, Amar Pal Singh, Ajeet Pal Singh , Parul Verma...
Review Article on Pharmacovigilance...
Jaspreet Kaur, Gaurav Hastir, Amar Pal Singh, Ajeet Pal Singh, Rajesh Kumar...
Review Article of Eye Cosmetic Product...
Sapna, Simran Kaur, Amar Pal Singh, Ajeet Pal Singh, Rajesh Kumar...
Related Articles
A Comprehensive Review Of Water Quality Analysis: Parameters, Analytical Methods...
A.Sarala, S.Kiruthiya, A.S.Kaviya Sri, M.Kaviya, Dr.S.K.Senthil Kumar...
A Comprehensive Review Of Water Quality Analysis: Parameters, Analytical Methods...
Hina Bagada, Sakshi singh, Jiya Patel, Sujal Patel, Saloni Thaker...
Comprehensive Review of Pazopanib with Low Oral Efficacy and Bioavailability...
Durga Madhab Nayak, Dr. Debasish Ghose, Dr.Sambit Kumar Parida...
More related articles
Comprehensive Review of Pazopanib with Low Oral Efficacy and Bioavailability...
Durga Madhab Nayak, Dr. Debasish Ghose, Dr.Sambit Kumar Parida...
A Comprehensive Review on RP-HPLC Method Development and Validation for Simultan...
Vanita Sawant, Pratiksha Wagh, Nikita Mawal, Smita Aher...
Analytical Method Development and Validation for Quantitative Estimation of Diso...
Arpit Shinganjude, Nandini Tale, Shrutika Kawane, Shyamkumar Dabhade, Mahesh Jadhao, Sajeeyaparveen ...
Comprehensive Review of Pazopanib with Low Oral Efficacy and Bioavailability...
Durga Madhab Nayak, Dr. Debasish Ghose, Dr.Sambit Kumar Parida...
A Comprehensive Review on RP-HPLC Method Development and Validation for Simultan...
Vanita Sawant, Pratiksha Wagh, Nikita Mawal, Smita Aher...
Analytical Method Development and Validation for Quantitative Estimation of Diso...
Arpit Shinganjude, Nandini Tale, Shrutika Kawane, Shyamkumar Dabhade, Mahesh Jadhao, Sajeeyaparveen ...